FDMT
NASDAQ · Biotechnology
4D Molecular Therapeutics In
$10.75
+0.20 (+1.90%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+96.4% upside
Low Target
$12.84
Average Target
$21.11
High Target
$26.25
Current Price
$10.75
Current
$10.75
$10.75
Target
$21.11
$21.11
$12.84
$21.11 avg
$26.25
Scenario Analysis
Bear Case
$12.84
19.4%
Low target
Base Case
$21.11
+96.4%
Avg target
Bull Case
$26.25
+144.2%
High target
Risk/Reward
7.4x
Highly favorable
Price in Context
52-Week High
$14.00
-23.2% from high
52-Week Low
$5.33
+101.7% from low
Target vs 52W High
$21.11
+50.8% vs high
Next Earnings Report
Aug 10, 2026
Today
EPS Est: $-1.03
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |